A review on α-glucosidase inhibitory activity of first row transition metal complexes: a futuristic strategy for treatment of type 2 diabetes

Author:

Sohrabi Marzieh1,Binaeizadeh Mohammad Reza2ORCID,Iraji Aida345,Larijani Bagher1,Saeedi Mina67ORCID,Mahdavi Mohammad1

Affiliation:

1. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

2. School of Chemistry, College of Science, University of Tehran, Tehran, Iran

3. Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

4. Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran

5. Liosa Pharmed Parseh Company, Shiraz, Iran

6. Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

7. Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Type 2 diabetes mellitus (T2DM) is characterized by high blood glucose levels and has emerged as a controversial public health issue worldwide.

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3